{
  "trial_id": "NCT01893801",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, Karnofsky Performance Status (KPS), life expectancy, tumor measurement according to RECIST 1.1 criteria, pregnancy status for women of childbearing potential, prior treatments in the adjuvant setting, history of other malignancies, serum creatinine levels, total bilirubin levels, alanine aminotransferase (ALT) levels, aspartate aminotransferase (AST) levels, absolute neutrophil count, platelet concentration, hematocrit level, coagulation tests (PT, PTT, INR), history of cardiac arrhythmias, history of HIV infection, presence of active infections, history of major surgery.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "CA19-9 Status at Baseline",
        "CEA Status at Baseline (if CA19-9 Normal at Baseline)",
        "CA125 Status at Baseline (if CA19-9 Normal at Baseline)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Status (KPS)",
        "life expectancy",
        "tumor measurement according to RECIST 1.1 criteria",
        "pregnancy status for women of childbearing potential",
        "prior treatments in the adjuvant setting",
        "history of other malignancies",
        "serum creatinine levels",
        "total bilirubin levels",
        "alanine aminotransferase (ALT) levels",
        "aspartate aminotransferase (AST) levels",
        "absolute neutrophil count",
        "platelet concentration",
        "hematocrit level",
        "coagulation tests (PT, PTT, INR)",
        "history of cardiac arrhythmias",
        "history of HIV infection",
        "presence of active infections",
        "history of major surgery"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Karnofsky Performance Status, Life Expectancy, Measurable Tumor Lesions, Prior Treatments, Laboratory Values (Serum Creatinine, Total Bilirubin, ALT, AST, Absolute Neutrophil Count, Platelet Concentration, Hematocrit Level, Coagulation Tests), History of Other Malignancies, History of HIV Infection, Active Infections, Major Surgery History,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)",
        "CA19-9 Status at Baseline",
        "CEA Status at Baseline (if CA19-9 Normal at Baseline)",
        "CA125 Status at Baseline (if CA19-9 Normal at Baseline)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Status",
        "Life Expectancy",
        "Measurable Tumor Lesions",
        "Prior Treatments",
        "Laboratory Values (Serum Creatinine, Total Bilirubin, ALT, AST, Absolute Neutrophil Count, Platelet Concentration, Hematocrit Level, Coagulation Tests)",
        "History of Other Malignancies",
        "History of HIV Infection",
        "Active Infections",
        "Major Surgery History"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Karnofsky Performance Status, Life Expectancy, Tumor Lesions, Prior Adjuvant Therapy, Prior Radiotherapy, Prior Surgery, Prior Chemotherapy, Prior Investigational Therapy, Laboratory Values (Serum Creatinine, Total Bilirubin, ALT, AST, Absolute Neutrophil Count, Platelet Concentration, Hematocrit Level, Coagulation Tests).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "CA19-9 Status at Baseline",
        "CEA Status at Baseline (if CA19-9 Normal at Baseline)",
        "CA125 Status at Baseline (if CA19-9 Normal at Baseline)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Karnofsky Performance Status",
        "Life Expectancy",
        "Tumor Lesions",
        "Prior Adjuvant Therapy",
        "Prior Radiotherapy",
        "Prior Surgery",
        "Prior Chemotherapy",
        "Prior Investigational Therapy",
        "Laboratory Values (Serum Creatinine, Total Bilirubin, ALT, AST, Absolute Neutrophil Count, Platelet Concentration, Hematocrit Level, Coagulation Tests)"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, Karnofsky Performance Status (KPS), life expectancy, presence of measurable tumor lesions, histological or cytological confirmation of metastatic pancreatic ductal adenocarcinoma, prior treatments in the adjuvant setting, laboratory values (serum creatinine, total bilirubin, alanine aminotransferase, aspartate aminotransferase, absolute neutrophil count, platelet concentration, hematocrit level, prothrombin time, partial thromboplastin time, International Normalized Ratio).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "CA19-9 Status at Baseline",
        "CEA Status at Baseline (if CA19-9 Normal at Baseline)",
        "CA125 Status at Baseline (if CA19-9 Normal at Baseline)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Status (KPS)",
        "life expectancy",
        "presence of measurable tumor lesions",
        "histological or cytological confirmation of metastatic pancreatic ductal adenocarcinoma",
        "prior treatments in the adjuvant setting",
        "laboratory values (serum creatinine, total bilirubin, alanine aminotransferase, aspartate aminotransferase, absolute neutrophil count, platelet concentration, hematocrit level, prothrombin time, partial thromboplastin time, International Normalized Ratio)"
      ]
    }
  }
}